Brazil Nut

Dosage for Brazil Nut extract is highly individualized and depends entirely on the method of administration and the patient's sensitivity levels.

• Skin Prick Testing (SPT): A single drop (approximately 0.05 mL) of the 1:10 or 1:20 w/v glycerinated extract is applied to the volar surface of the forearm or the back. A sterile lancet is then used to prick the skin through the drop.
• Intradermal Testing: If the SPT is negative but clinical suspicion remains high, a healthcare provider may administer 0.02 to 0.05 mL of a 1:100 to 1:1000 v/v dilution intradermally (into the skin layers).
• Oral Immunotherapy (OIT): This is performed only in specialized centers. Dosing starts as low as 0.01 mg of Brazil Nut protein and is gradually increased (up-dosed) over several months to a maintenance dose of 300 mg to 4000 mg, depending on the protocol.

Brazil Nut allergenic extract is approved for use in pediatric populations for diagnostic purposes.

• Infants and Children: The procedure for skin prick testing is identical to that for adults, though the back is often the preferred site to prevent the child from interfering with the test.
• Safety Note: Pediatric patients are at a higher risk for systemic reactions during testing; therefore, testing should be performed by a board-certified allergist.

Renal Impairment

No specific dosage adjustments are required for diagnostic skin testing in patients with renal impairment, as systemic absorption is minimal. However, in immunotherapy, clinicians should monitor for altered clearance of inflammatory mediators.

Hepatic Impairment

Patients with significant hepatic impairment may have altered protein synthesis, potentially affecting their baseline histamine levels or skin reactivity. No formal dose adjustment is established, but results should be interpreted with caution.

Elderly Patients

Elderly patients may exhibit reduced skin reactivity (reduced wheal and flare response) due to age-related changes in skin physiology and mast cell density. A positive control (histamine) is crucial in this population to ensure the validity of the test.

Brazil Nut extract is not 'taken' in the traditional sense like a pill. It is administered by a healthcare professional.

• Preparation: The skin site must be cleaned with alcohol and allowed to dry.
• Administration: For testing, the extract is applied topically or injected intradermally. For immunotherapy, it is mixed with a vehicle (like applesauce or pudding) and consumed orally under medical supervision.
• Storage: The extract must be stored in a refrigerator at 2°C to 8°C (36°F to 46°F). It should not be frozen. Keep the vial tightly closed to prevent evaporation and contamination.

In the context of diagnostic testing, a missed appointment simply delays diagnosis. However, in Oral Immunotherapy (OIT), a missed dose is a critical safety issue:

• One Missed Dose: Usually, the patient can continue the current dose the next day.
• Two or More Missed Doses: The patient must contact their allergist. A 'dose reduction' or 're-escalation' may be necessary to prevent an allergic reaction due to lost desensitization.

An overdose of Brazil Nut extract (either too much in a skin test or an error in immunotherapy) can lead to Anaphylaxis.

• Signs of Overdose: Hives, swelling of the throat, wheezing, difficulty breathing, rapid pulse, and a sharp drop in blood pressure.
• Emergency Measures: Administration of intramuscular epinephrine (EpiPen) is the first-line treatment. Seek emergency medical attention immediately (call 911).

> Important: Follow your healthcare provider's dosing instructions exactly. Do not attempt to self-administer allergenic extracts or perform 'home challenges' with Brazil Nuts if an allergy is suspected.

Most patients undergoing testing or treatment with Brazil Nut extract will experience localized reactions. These are typically expected and indicate the extract is biologically active.

• Localized Pruritus (Itching): Intense itching at the site of the skin prick or intradermal injection. This usually begins within 5 minutes and peaks at 15-20 minutes.
• Wheal and Flare: A raised, red bump (wheal) surrounded by a larger area of redness (flare). This is the hallmark of a positive diagnostic test.
• Oral Itching (OAS): In immunotherapy patients, an itchy mouth or throat is very common after consuming the dose.

• Large Local Reactions: Swelling that extends beyond the immediate test site, sometimes involving the entire upper arm.
• Urticaria (Hives): Hives appearing in areas away from the test site, indicating a mild systemic response.
• Gastrointestinal Distress: Mild abdominal cramping or nausea, particularly in patients undergoing oral desensitization.

• Delayed Cutaneous Reactions: Swelling or redness that appears 6 to 24 hours after the extract was administered.
• Lymphadenopathy: Swelling of the lymph nodes near the site of administration.
• Estrogenic Effects: Due to its Estrogen Receptor Agonist [MoA] properties, rare reports of breast tenderness or menstrual spotting have been noted in sensitive individuals receiving high-dose immunotherapy, though this is clinically rare.

> Warning: Stop the administration or ingestion of Brazil Nut and call your doctor immediately if you experience any of these symptoms of anaphylaxis.

• Respiratory Distress: Shortness of breath, wheezing, or a feeling of 'tightness' in the chest.
• Angioedema: Significant swelling of the lips, tongue, or throat that may obstruct the airway.
• Hypotension (Shock): Feeling faint, dizzy, or passing out due to a sudden drop in blood pressure.
• Cardiac Arrhythmia: A rapid or irregular heartbeat.
• Cyanosis: Bluish tint to the lips or fingernails, indicating lack of oxygen.

Prolonged exposure to Brazil Nut allergenic extracts, particularly in immunotherapy, can lead to:

• Eosinophilic Esophagitis (EoE): A chronic immune system disease where eosinophils (a type of white blood cell) build up in the lining of the esophagus, causing difficulty swallowing or food impaction.
• Persistent Sensitization: In some cases, testing or low-dose exposure can inadvertently increase a patient's sensitivity levels rather than decreasing them.

No FDA black box warnings are currently issued for Brazil Nut allergenic extracts. However, all allergenic extracts carry a general warning regarding the risk of severe non-fatal and fatal systemic anaphylaxis. These products must only be used by clinicians who are experienced in the administration of allergenic extracts and the treatment of anaphylaxis.

Report any unusual symptoms or delayed reactions to your healthcare provider. Even a 'mild' reaction during one visit can precede a 'severe' reaction during the next.

Brazil Nut allergenic extract is a potent biological substance. It should never be used outside of a controlled medical environment. Patients with a known history of severe anaphylaxis to tree nuts must be approached with extreme caution, as even the minute amount of protein in a skin prick test can trigger a systemic reaction.

No FDA black box warnings for Brazil Nut. However, the FDA requires all allergenic extracts to include a prominent warning that they can cause severe systemic reactions, including anaphylaxis, which can be fatal. Epinephrine must always be available during administration.

• Anaphylaxis Risk: This is the primary concern. Patients must be observed for at least 30 minutes following any skin testing or immunotherapy dose.
• Asthma Status: Patients with uncontrolled or severe asthma are at a significantly higher risk for a fatal outcome if an allergic reaction occurs. Asthma must be stable before testing.
• Estrogenic Activity: Because Brazil Nut acts as an Estrogen Receptor Agonist [MoA], patients with estrogen-sensitive conditions (e.g., certain breast cancers, uterine fibroids, or endometriosis) should discuss the potential risks with their oncologist or gynecologist before high-dose or long-term exposure.
• Cardiovascular Disease: Patients with pre-existing heart conditions may not tolerate the stress of a systemic reaction or the side effects of epinephrine if it must be administered.

• Observation: A 30-minute post-administration wait time is mandatory.
• Peak Flow: For asthmatic patients, a peak flow meter may be used to check lung function before and after administration.
• Vital Signs: Blood pressure and heart rate monitoring in patients with a history of severe reactions.
• Eosinophil Counts: Periodic monitoring if Eosinophilic Esophagitis is suspected during long-term immunotherapy.

Brazil Nut extract itself does not cause sedation. However, if a systemic reaction occurs or if antihistamines/epinephrine are administered to treat a reaction, these can significantly impair your ability to drive or operate machinery. Do not drive if you feel dizzy or unwell after a clinical visit.

Alcohol should be avoided for several hours before and after administration of Brazil Nut extract. Alcohol increases blood flow to the skin and can accelerate the systemic absorption of the allergen, potentially turning a local reaction into a systemic one.

If you are undergoing immunotherapy, do not stop the treatment suddenly without consulting your allergist. Sudden discontinuation will result in a loss of desensitization, making you once again vulnerable to severe reactions from accidental ingestion of Brazil Nuts.

> Important: Discuss all your medical conditions, especially respiratory or heart issues, with your healthcare provider before starting Brazil Nut testing or treatment.

• Beta-Blockers (e.g., Propranolol, Atenolol): These medications are contraindicated in patients undergoing allergenic extract testing or treatment. The reason is not a direct interaction with Brazil Nut, but rather that beta-blockers prevent epinephrine from working effectively. If the patient has an anaphylactic reaction to the Brazil Nut, the life-saving treatment (epinephrine) may fail.
• MAO Inhibitors (e.g., Phenelzine): These can potentiate the effects of pressor amines used to treat reactions, leading to hypertensive crises.

• ACE Inhibitors (e.g., Lisinopril): Similar to beta-blockers, ACE inhibitors can interfere with the body's compensatory mechanisms during anaphylaxis and may worsen the severity of the reaction.
• Tricyclic Antidepressants (TCAs): These can increase the skin's sensitivity to histamine, potentially leading to false-positive results in diagnostic testing.

• Antihistamines (e.g., Loratadine, Cetirizine): These must be discontinued 3 to 7 days before diagnostic testing. They block the H1 receptors, which prevents the 'wheal and flare' reaction, leading to a false-negative test result.
• H2 Blockers (e.g., Famotidine): These can also mildly suppress skin reactivity and should be discontinued prior to testing.
• Systemic Corticosteroids: Long-term use of oral steroids (like Prednisone) can thin the skin and reduce the inflammatory response, potentially masking a positive test result.

• Cross-Reactive Foods: Patients sensitive to Brazil Nut may also react to other members of the Lecythidaceae family or other tree nuts (like walnuts or cashews) due to protein similarity. This is known as 'cross-reactivity.'
• High-Fat Meals: Since Brazil Nut has Lipid Emulsion [EPC] properties, consuming a high-fat meal immediately before oral immunotherapy may alter the rate of protein absorption in the gut.

• Phytoestrogens (e.g., Soy Isoflavones, Red Clover): Since Brazil Nut acts as an Estrogen Receptor Agonist [MoA], taking other estrogenic supplements may have an additive effect, potentially influencing hormonal balance.
• St. John's Wort: May alter the metabolism of various components through CYP450 induction, though the clinical significance for allergenic extracts is low.

• Serum Tryptase: Brazil Nut administration during a reaction will cause a significant rise in serum tryptase levels, which is used as a diagnostic marker for anaphylaxis.
• Skin Tests: As mentioned, antihistamines and certain antidepressants will interfere with the accuracy of the skin test results.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially those for blood pressure or allergies.

Brazil Nut allergenic extract must NEVER be used in the following circumstances:

• Recent Anaphylaxis: If a patient has had a systemic allergic reaction to any substance within the last 24 hours, their mast cells may be 'depleted' or 'hyper-irritable,' making testing dangerous or inaccurate.
• Severe, Uncontrolled Asthma: The risk of a fatal bronchospasm during a reaction is too high. FEV1 (Forced Expiratory Volume) should typically be >80% of predicted before testing.
• Beta-Blocker Therapy: As noted, the inability to respond to epinephrine is an absolute contraindication for elective allergenic testing.
• Active Skin Disease: Conditions like generalized eczema or urticaria (hives) at the test site make it impossible to interpret the results.

• Pregnancy: While not strictly forbidden, diagnostic skin testing is usually postponed until after delivery to avoid the risk of anaphylaxis-induced uterine contractions or fetal hypoxia.
• Autoimmune Disorders: Patients with active systemic lupus erythematosus (SLE) or other autoimmune conditions may have unpredictable immune responses to the extract.
• Malignancy: Especially estrogen-sensitive cancers, due to the Estrogen Receptor Agonist [MoA] profile of the extract.

Patients who are allergic to Walnuts, Pecans, or Cashews may exhibit cross-sensitivity to Brazil Nut extract. Additionally, individuals with a known allergy to Latex may react to Brazil Nut due to the presence of Hevein-like proteins.

> Important: Your healthcare provider will evaluate your complete medical history, including your current medications and asthma control, before prescribing or administering Brazil Nut extract.

FDA Pregnancy Category C. There are no adequate and well-controlled studies of Brazil Nut allergenic extract in pregnant women. The primary risk is not the extract itself, but the potential for a systemic allergic reaction (anaphylaxis). Anaphylaxis in the mother can cause a sudden drop in blood pressure, leading to placental hypoperfusion (lack of blood flow to the baby) and fetal distress. Therefore, diagnostic testing is generally avoided during pregnancy unless the information is vital for the mother's immediate safety.

It is not known whether Brazil Nut allergenic proteins or its estrogenic components pass into human breast milk. Because most components are proteins that are digested in the infant's gut, the risk is considered low. However, breastfeeding mothers should be monitored for any signs of allergic reactions in the nursing infant, especially if the mother is undergoing high-dose oral immunotherapy.

Brazil Nut extract is frequently used in children as young as 6 months of age for diagnostic purposes.

• Efficacy: Skin testing is highly effective in the pediatric population.
• Safety: Children have a smaller physiological reserve; therefore, systemic reactions can progress more quickly.
• Growth Effects: There is no evidence that diagnostic testing affects growth. However, the Estrogen Receptor Agonist [MoA] properties are a theoretical concern for long-term, high-dose immunotherapy in prepubescent children, though not observed in standard clinical practice.

In patients over 65, several factors must be considered:

• Reduced Reactivity: Aging skin may produce smaller wheals, leading to potential under-diagnosis.
• Cardiovascular Risk: The elderly are more likely to have underlying heart disease, making them poor candidates for the physiological stress of anaphylaxis or the administration of epinephrine.
• Polypharmacy: Older adults are often on beta-blockers or ACE inhibitors, which are contraindicated or require caution.

No dosage adjustments are needed for skin testing. In the rare case of systemic absorption during high-dose research protocols, the clearance of nitrogenous metabolites of the proteins may be delayed in patients with a GFR < 30 mL/min.

In patients with severe liver disease (Child-Pugh Class C), the metabolism of the lipid components (Lipid Emulsion [EPC]) and the synthesis of complement proteins may be affected. Clinical monitoring for atypical inflammatory responses is advised.

> Important: Special populations require individualized medical assessment by a specialist in allergy and immunology.

Brazil Nut extract functions as a complex biological agent. Its primary diagnostic mechanism involves the IgE-mediated activation of mast cells. The major allergen, Ber e 1, is a 2S albumin protein that is highly stable. Upon contact with the skin or mucosa, it cross-links specific IgE antibodies on mast cells, triggering the release of histamine.

Furthermore, the extract is classified as an Estrogen Receptor Agonist [MoA]. It contains phytoestrogens and specific lipids that can bind to the ligand-binding domain of estrogen receptors. This binding induces a conformational change that allows the receptor to dimerize and bind to Estrogen Response Elements (EREs) in the DNA, promoting the transcription of estrogen-regulated genes. This dual action as both an allergen and a hormonal modulator is a unique pharmacological characteristic of the Bertholletia excelsa species.

• Onset of Action: For skin testing, the onset is rapid (5–15 minutes).
• Duration of Effect: The localized wheal and flare reaction typically resolves within 2 to 4 hours. Systemic immunological sensitization, however, can persist for a lifetime.
• Dose-Response: There is a clear dose-response relationship in skin testing; higher concentrations of the extract produce larger wheals, up to a saturation point.

| Parameter | Value |

|---|---|

| Bioavailability | <1% (Skin Prick); >40% (Oral) |

| Protein Binding | High (to IgE and Albumin) |

| Half-life | 2–6 hours (Systemic proteins) |

| Tmax | 15–30 minutes (Skin reaction) |

| Metabolism | Proteolysis (Proteins); Hepatic (Lipids) |

| Excretion | Renal (Metabolites) |

• Molecular Formula: Complex mixture (Major protein Ber e 1: C562H912N166O166S12)
• Molecular Weight: ~12 kDa to 18 kDa for major allergenic proteins.
• Solubility: Proteins are water-soluble; lipid components are fat-soluble.
• Structure: The 2S albumin consists of two subunits (a large and a small subunit) linked by disulfide bonds, creating a compact, globular structure resistant to denaturation.

Brazil Nut is classified as a Non-Standardized Food Allergenic Extract [EPC]. It shares clinical characteristics with other tree nut extracts but is unique due to its specific protein profile and its secondary classification as an Endoglycosidase [EPC] and Estrogen [EPC] agent.